CYP2D6 and movement disorder: If the link between reduced risperidone metabolism by CYP2D6 PMs and movement disorders was as clear as has previously been described (de Leon et al., 2005a, Bozina et al., 2008), the majority of this cohort would have been expected to be PMs.